Cell populations before extracorporeal photochemotherapy and 6 and 12 months afterward
Patient . | CD4-CD8 cell ratio . | CD56 NK cells . | CD80 (%)/CD123 (%) cells . | ||||||
---|---|---|---|---|---|---|---|---|---|
Before . | 6 mo . | 12 mo . | Before . | 6 mo . | 12 mo . | Before . | 6 mo . | 12 mo . | |
1 | 0.08 | 0.56 | 0.9 | 12 | 20 | 61 | 5/16 | 5/35 | 1/4 |
2 | 0.2 | 0.2 | — | 1.3 | 7.2 | — | —/7.2 | —/2.7 | — |
3 | 0.4 | 0.2 | 0.5 | 24 | 45 | 21 | 7/16 | 4/6 | 4/12 |
4 | 0.6 | 0.37 | 0.3 | 12 | 16 | 35 | 7.4/17 | 6.5/12.7 | 1.7/3.8 |
5 | 0.2 | 1.2 | — | 15.3 | 39 | — | 1.0/0.5 | 0/0.9 | — |
6 | 0.2 | 0.3 | 0.25 | 1.3 | 8 | 7 | 0.8/6 | 0.2/2 | 0.25/2 |
7 | 1.95 | 2.15 | 0.014 | 25 | 33 | 97 | 11/22 | 1.3/13 | 0.5/2.9 |
8 | 0.35 | 0.16 | 0.33 | 92 | 57 | 64 | 3.9/16 | 4.5/11 | 0.62/5.4 |
9 | 0.06 | 0.03 | 0.3 | 27 | 52 | 64 | 12/16 | 5/8 | 2/4.8 |
10 | 0.2 | 0.02 | 0.12 | 23 | 62 | 48 | 4/7 | 29/37 | 23/28 |
Patient . | CD4-CD8 cell ratio . | CD56 NK cells . | CD80 (%)/CD123 (%) cells . | ||||||
---|---|---|---|---|---|---|---|---|---|
Before . | 6 mo . | 12 mo . | Before . | 6 mo . | 12 mo . | Before . | 6 mo . | 12 mo . | |
1 | 0.08 | 0.56 | 0.9 | 12 | 20 | 61 | 5/16 | 5/35 | 1/4 |
2 | 0.2 | 0.2 | — | 1.3 | 7.2 | — | —/7.2 | —/2.7 | — |
3 | 0.4 | 0.2 | 0.5 | 24 | 45 | 21 | 7/16 | 4/6 | 4/12 |
4 | 0.6 | 0.37 | 0.3 | 12 | 16 | 35 | 7.4/17 | 6.5/12.7 | 1.7/3.8 |
5 | 0.2 | 1.2 | — | 15.3 | 39 | — | 1.0/0.5 | 0/0.9 | — |
6 | 0.2 | 0.3 | 0.25 | 1.3 | 8 | 7 | 0.8/6 | 0.2/2 | 0.25/2 |
7 | 1.95 | 2.15 | 0.014 | 25 | 33 | 97 | 11/22 | 1.3/13 | 0.5/2.9 |
8 | 0.35 | 0.16 | 0.33 | 92 | 57 | 64 | 3.9/16 | 4.5/11 | 0.62/5.4 |
9 | 0.06 | 0.03 | 0.3 | 27 | 52 | 64 | 12/16 | 5/8 | 2/4.8 |
10 | 0.2 | 0.02 | 0.12 | 23 | 62 | 48 | 4/7 | 29/37 | 23/28 |